A potential treatment for peanut allergy is being studied and probiotics are the star.

62 children with an allergy to peanuts participated in the Australian double blind, placebo-controlled randomised trial at Murdoch University, using the probiotic Lactobacillus rhamnosus GG at a dose of 20 billion colony forming units or placebo, combined with peanut oral immunotherapy over 18 months.

By the end of the trial, 89% of the patients receiving the active treatment were desensitised to the peanut protein compared to 7% in the placebo group. This trial was performed under close medical supervision, but it does pave the way for a potential probiotic-based solution to this both inconvenient and life-threatening problem.

We have the probiotic Lactobacillus rhamnosus GG available for sale.There is scientific evidence that this probiotic can influence the immune system and provide the protection that is necessary to stop allergies developing.